Skip to main content

Peer Review reports

From: MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer

Original Submission
11 Jun 2022 Submitted Original manuscript
21 Aug 2022 Reviewed Reviewer Report - Jasvinder Singh
26 Aug 2022 Reviewed Reviewer Report
13 Sep 2022 Author responded Author comments - Wang Gongxian
Resubmission - Version 2
13 Sep 2022 Submitted Manuscript version 2
22 Sep 2022 Author responded Author comments - Wang Gongxian
Resubmission - Version 3
22 Sep 2022 Submitted Manuscript version 3
24 Sep 2022 Author responded Author comments - Wang Gongxian
Resubmission - Version 4
24 Sep 2022 Submitted Manuscript version 4
25 Sep 2022 Author responded Author comments - Wang Gongxian
Resubmission - Version 5
25 Sep 2022 Submitted Manuscript version 5
14 Oct 2022 Reviewed Reviewer Report
24 Oct 2022 Reviewed Reviewer Report - Jasvinder Singh
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
31 Oct 2022 Editorially accepted
11 Nov 2022 Article published 10.1186/s12885-022-10259-2

You can find further information about peer review here.

Back to article page